Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript

Question-and-Answer SessionSo starting off sort of high level on the 1Q overview. You posted an organic decline of 1%. Can you just give us a quick overview of the quarter and I guess, the macro environment as you see it today?James HippelExecutive VP of Finance & CFO Yes. Let me start with what I see as our highlights for the quarter from an end market perspective. Large pharma continues to perform very well for us. As a reminder, large pharma is about 30% of our revenue. We had like the third quarter in a ...